Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2005; 93(02): 359-367
DOI: 10.1160/TH04-05-0319
DOI: 10.1160/TH04-05-0319
Cellular Proteolysis and Oncology
Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis
Financial support: This study was supported from the Japan Society for Promoting Science (JSPS): Future Developmental Research (to Y. C.) and Young Scientists Fellowship B (to S. I.).
Further Information
Publication History
Received
21 May 2004
Accepted after revision
29 January 2004
Publication Date:
11 December 2017 (online)
Summary
The plasma kallikrein-kinin system inhibitor, haemaphysalin, from the hard tick, Haemaphysalis longicornis, was identified. It was found that haemaphysalin inhibited activation of the plasma kallikrein-kinin system by interfering with reciprocal activation between factor XII and prekallikrein. It did not, however, inhibit amidolytic activities of factor XIIa and kallikrein. Direct binding assay indicated that factor XII/XIIa and high molecular weight kininogen (HK) are the target molecules of haemaphysalin, and that Zn2+ ions are involved in the interactions of haemaphysalin with these target molecules. This suggests that haemaphysalin interacts with target molecules by recognizing their conformational changes induced by Zn2+ ions. Furthermore, haemaphysalin interacted with the fibronectin type II domain and domain D5, the cell binding domains of factor XII and HK, respectively. This finding suggests that haemaphysalin interferes with the association of factor XII and the prekallikrein-HK complex with a biologic activating surface by binding to these cell-binding domains, leading to inhibition of the reciprocal activation between factor XII and prekallikrein.
-
References
- 1 Røjkjær R, Hasan AA, Motta G. et al Factor XII does not initiate prekallikrein activation on endothelial cells.. Thromb Haemost 1998; 80: 74-81.
- 2 Regoli D, Barabe J. Pharmacology of bradykinin and related kinins.. Pharmac Rev 1980; 32: 1-36.
- 3 Saito H. Contact factor in health and disease. Semin Thromb Hemost 1987; 13: 36-49.
- 4 Motta G, Røjkjær R, Hasan AA. et al High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cell: a novel mechanism for contact activation.. Blood 1998; 91: 516-28.
- 5 Shariat-Madar Z, Mahdi F, Schmaier AH. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.. J Biol Chem 2002; 277: 17962-9.
- 6 Moreira CR, Schmaier AH, Mahdi F. et al Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator.. FEBS Lett 2002; 523: 167-70.
- 7 Shariat-Madar Z, Mahdi F, Schmaier AH. Recombinant prolylcarboxypepetidase activates plasma prekallikrein.. Blood 2004; 103: 4554-61.
- 8 Shimada T, Kato H, Iwanaga S. Accelating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.. J Biochem 1987; 102: 913-21.
- 9 Schousboe I, Halker T. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.. Eur J Biochem 1991; 197: 309-14.
- 10 Røjkjær R, Schousboe I. The surface-dependant autoactivation mechanism of factor XII.. Eur J Biochem 1997; 243: 160-6.
- 11 van Iwaarden F, de Groot PG, Bouma BN. The binding of high molecular weight kininogen to cultured human endothelial cells.. J Biol Chem 1988; 263: 4698-703.
- 12 Bernardo MM, Day DE, Olson ST. et al Surface –independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement.. J Biol Chem 1993; 268: 12468-76.
- 13 Bernardo MM, Day DE, Halvorson HR. et al Surface- independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.. J Biol Chem 1993; 268: 12477-83.
- 14 Herwald H, Morgelin M, Svensson HG. et al Zincdependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation.. Eur J Biochem 2001; 268: 396-404.
- 15 Reddigari SR, Shibayama Y, Bruuee T. et al Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cell.. J Biol Chem 1993; 268: 11982-7.
- 16 Joseph K, Ghebrehiwet B, Peerschke I E. et al Identification of zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII; identity with the receptor that cell binds to the globular "heads" of C1q (gC1q-R).. Proc Natl Acad Sci USA 1996; 93: 8552-7.
- 17 Mahdi F, Madar ZS, Figueroa CD. et al Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.. Blood 2002; 99: 3585-96.
- 18 Stark KR, James AA. Anticoagulants in vector arthropods.. Parasitol Today 1996; 12: 430-7.
- 19 Anguita J, Ramamoorthi N, Hovius JWR. et al Salp15, an Ixodes scapularis salivary protein, inhibits CD4 (+) T cell activation.. Immunity 2002; 16: 849-59.
- 20 Valenzuela JG, Charlab R, Mather TN. et al Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis.. J Biol Chem 2000; 275: 18717-23.
- 21 Waxman L, Connoly TM. Isolation of an inhibitor selective for collagen-stimulated platelet aggregation from the soft tick Ornithodoros moubata.. J Biol Chem 1993; 268: 5445-9.
- 22 Keller PM, Waxmann L, Arnold BA. et al Cloning of the cDNA and expression of moubatin, an inhibitor of platelet aggregation.. J Biol Chem 1993; 268: 5450-6.
- 23 Ribeiro JMC. Role of saliva in blood-feeding by arthropods.. Annu Rev Entomol 1987; 32: 463-78.
- 24 Francischetti IMB, Valenzuela JG, Andersen JF. et al Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.. Blood 2002; 99: 3602-12.
- 25 Waxman L, Smith DE, Arcuri KE. et al Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa.. Science 1990; 248: 593-6.
- 26 Mans BJ, Louw AI, Neitz AW. Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the Kunitz-BPTI fold.. J Biol Chem 2002; 277: 21371-8.
- 27 Valenzuela JG, Francischetti IMB, Pham VM. et al Exploring the sialome of the tick Ixodes scapularis.. J Exp Biol 2002; 205: 2843-64.
- 28 Altman JD, Henner D, Nilsson B. et al Intracellular expression of BPTI fusion proteins and single column cleavage/affinity purification by chymotrypsin.. Protein Eng 1991; 4: 593-600.
- 29 Tsuruta H, Tsuneta ST, Ishida Y. et al Purification and some characteristics of phosphatase of a psychrophile.. J Biochem 1998; 123: 219-25.
- 30 Bajaj SP, Joist JH. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.. Semin Thromb Hemost 1999; 25: 407-18.
- 31 Ulmer JS, Lindquist RN, Dennis MS. et al Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein.. FEBS Lett 1995; 365: 159-63.
- 32 Scott CF, Colman RW. A simple and accurate microplate assay for the determination of factor XI in plasma.. J Lab Clin Med 1988; 111: 708-14.
- 33 De La Cadena RA, Scott CF, Colman RW. Evaluation of a microassay for human plasma prekallikrein.. J Lab Clin Med 1987; 109: 601-7.
- 34 Tankersley DL, Alving BM, Finlayson JS. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.. Blood 1983; 62: 448-56.
- 35 Hoem NO, Johannesen S, Briseid K. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.. Thromb Res 1989; 54: 197-205.
- 36 Samuel M, Pixley RA, Villanueva MA. et al Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.. J Biol Chem 1992; 267: 19691-7.
- 37 Citarella F, Wuillemin WA, Lubbers YT. et al Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.. Br J Haematol 1997; 99: 197-205.
- 38 van de Locht A, Stubbs MT, Bode W. et al The ornithodorin- thrombin crystal structure, a key to the TAP enigma?. EMBO J 1996; 15: 6011-7.
- 39 Røjkjær R, Schousboe I. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives.. Eur J Biochem 1997; 247: 491-6.
- 40 De La Cadena RA, Colman RW. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.. Protein Sci 1992; 1: 151-60.
- 41 Hasan AA, Cines DB, Herwald H. et al Mapping the cell binding site on high molecular weight kininogen domain 5.. J Biol Chem 1995; 270: 19256-61.